Pharmacological and/or dietary induction of the Nrf2/HO-1/NQO1 pathway may serve as a therapeutic strategy to prevent oxidative stress-induced damage in the peripheral vessels or the blood–brain barrier in stroke [185]. This evidence concerns the gene NFE2L2 and stroke disorder.